RE:Octapharma 2014 Annual Report is outplilong.....thank you for this report....I find it very interesting , especially the part where it says they will also significantly increase the overall efficiency of manufacturing operations. While speculative..prometics process does just that.
In 2014, we launched “Program 2019” which aims to double production capacity of fractionation and recombinant production by 2019, while significantly increasing the overall efficiency of manufacturing operations. The program includes more than 50 projects with a total investment of around 400 Mio Euros over 5 years. Major increases in capacity will come into effect by mid-2016
Read more at https://www.stockhouse.com/companies/bullboard/t.pli/prometic-life-sciences-inc#mDx92SIu33kIzLcT.99